. Il-est-À-noter and . Qu, il en est de même concernant les complications de la cirrhose, avec par exemple moins d'ascite chez les patients NASH, ainsi que moins de développement de carcinome hépatocellulaire. Mais le rapport s'inversait concernant la mortalité cardiovasculaire plus importante

V. Ratziu, S. Bellentani, H. Cortez-pinto, C. Day, and G. Marchesini, A position statement on NAFLD/NASH based on the EASL 2009 special conference, Journal of Hepatology, vol.53, issue.2, pp.372-84, 2010.
DOI : 10.1016/j.jhep.2010.04.008

M. Armstrong, L. Adams, A. Canbay, and W. Syn, Extrahepatic complications of nonalcoholic fatty liver disease, Hepatology, vol.41, issue.3, pp.1174-97, 2014.
DOI : 10.1002/hep.20704

G. Targher, C. Day, and E. Bonora, Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease, New England Journal of Medicine, vol.363, issue.14, pp.1341-50, 2010.
DOI : 10.1056/NEJMra0912063

N. Chalasani, Z. Younossi, J. Lavine, A. Diehl, E. Brunt et al., The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the, American College of Gastroenterology, and the American Gastroenterological Association, 2012.

A. Sanyal, E. Brunt, D. Kleiner, K. Kowdley, N. Chalasani et al., Endpoints and clinical trial design for nonalcoholic steatohepatitis, Hepatology, vol.361, issue.1, pp.344-53, 2011.
DOI : 10.1056/NEJMp0905338

G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi et al., Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome, Diabetes, vol.50, issue.8, pp.1844-50, 2001.
DOI : 10.2337/diabetes.50.8.1844

E. Powell, J. Jonsson, and A. Clouston, Steatosis: Co-factor in other liver diseases, Hepatology, vol.42, issue.1, pp.5-13, 2005.
DOI : 10.1152/ajpgi.00426.2001

A. Suzuki, P. Angulo, J. Lymp, S. Sauver, J. Muto et al., Chronological development of elevated aminotransferases in a nonalcoholic population, Hepatology, vol.139, issue.1, pp.64-71, 2005.
DOI : 10.7326/0003-4819-139-10-200311180-00007

M. Hamaguchi, T. Kojima, N. Takeda, T. Nakagawa, H. Taniguchi et al., The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease, Annals of Internal Medicine, vol.143, issue.10, pp.722-730, 2005.
DOI : 10.7326/0003-4819-143-10-200511150-00009

S. Whalley, P. Puvanachandra, A. Desai, and H. Kennedy, Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs, Clinical Medicine, vol.7, issue.2, pp.119-143, 2007.
DOI : 10.7861/clinmedicine.7-2-119

G. Bedogni, L. Miglioli, F. Masutti, A. Castiglione, L. Crocè et al., Incidence and natural course of fatty liver in the general population: The Dionysos study, Hepatology, vol.27, issue.Suppl 1, pp.1387-91, 2007.
DOI : 10.1161/01.ATV.0000251993.20372.40

J. Lee, K. Kim, S. Lee, E. Yu, Y. Lim et al., Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center, Journal of Hepatology, vol.47, issue.2, pp.239-283, 2007.
DOI : 10.1016/j.jhep.2007.02.007

G. Vernon, A. Baranova, and Z. Younossi, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Alimentary Pharmacology & Therapeutics, vol.11, issue.6 Pt 2, pp.274-85, 2011.
DOI : 10.1016/j.cld.2007.02.002

C. Williams, J. Stengel, M. Asike, D. Torres, J. Shaw et al., Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study, Gastroenterology, vol.140, issue.1, pp.124-155, 2011.
DOI : 10.1053/j.gastro.2010.09.038

J. Browning, L. Szczepaniak, R. Dobbins, P. Nuremberg, J. Horton et al., Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity, Hepatology, vol.83, issue.6, pp.1387-95, 2004.
DOI : 10.2105/AJPH.89.1.14

M. Machado, P. Marques-vidal, and H. Cortez-pinto, Hepatic histology in obese patients undergoing bariatric surgery, Journal of Hepatology, vol.45, issue.4, pp.600-606, 2006.
DOI : 10.1016/j.jhep.2006.06.013

C. Boza, A. Riquelme, L. Ibañez, I. Duarte, E. Norero et al., Predictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass, Obesity Surgery, vol.15, issue.8, pp.1148-53, 2005.
DOI : 10.1381/0960892055002347

P. Haentjens, D. Massaad, H. Reynaert, E. Peeters, A. Van-meerhaeghe et al., IDENTIFYING NON-ALCOHOLIC FATTY LIVER DISEASE AMONG ASYMPTOMATIC OVERWEIGHT AND OBESE INDIVIDUALS BY CLINICAL AND BIOCHEMICAL CHARACTERISTICS, Acta Clinica Belgica, vol.107, issue.121, pp.483-93, 2009.
DOI : 10.1503/cmaj.050090

P. Colicchio, G. Tarantino, F. Del-genio, P. Sorrentino, G. Saldalamacchia et al., Non-Alcoholic Fatty Liver Disease in Young Adult Severely Obese Non-Diabetic Patients in South Italy, Annals of Nutrition and Metabolism, vol.49, issue.5, pp.289-95, 2005.
DOI : 10.1159/000087295

C. Beymer, K. Kowdley, A. Larson, P. Edmonson, E. Dellinger et al., Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery, Archives of Surgery, vol.138, issue.11, pp.1240-1244, 2003.
DOI : 10.1001/archsurg.138.11.1240

N. Leite, G. Salles, A. Araujo, C. Villela-nogueira, and C. Cardoso, Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus, Liver International, vol.29, issue.1, pp.113-122, 2009.
DOI : 10.1111/j.1478-3231.2008.01718.x

M. Prashanth, H. Ganesh, M. Vima, M. John, T. Bandgar et al., Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus, J Assoc Physicians India. mars, vol.57, pp.205-215, 2009.

N. Assy, K. Kaita, D. Mymin, C. Levy, B. Rosser et al., Fatty infiltration of liver in hyperlipidemic patients, Digestive Diseases and Sciences, vol.45, issue.10, pp.1929-1963, 2000.
DOI : 10.1023/A:1005661516165

H. Li, Y. Wang, K. Tan, L. Zeng, L. Liu et al., Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China, HBPD INT. août, vol.8, issue.4, pp.377-82, 2009.

D. Amarapurkar, P. Kamani, N. Patel, P. Gupte, P. Kumar et al., Prevalence of nonalcoholic fatty liver disease: population based study, Ann Hepatol. sept, vol.6, issue.3, pp.161-164, 2007.

J. Frith, C. Day, E. Henderson, A. Burt, and J. Newton, Non-Alcoholic Fatty Liver Disease in Older People, Gerontology, vol.55, issue.6, pp.607-620, 2009.
DOI : 10.1159/000235677

Z. Chen, L. Chen, H. Dai, J. Chen, and L. Fang, Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease, Journal of Zhejiang University SCIENCE B, vol.9, issue.8, pp.616-638, 2008.
DOI : 10.1631/jzus.B0720016

G. Fischer, S. Bialek, C. Homan, S. Livingston, and B. Mcmahon, Chronic Liver Disease among Alaska-Native People, 2003???2004, The American Journal of Gastroenterology, vol.137, issue.2, pp.363-70, 2003.
DOI : 10.7326/0003-4819-137-1-200207020-00006

S. Bialek, J. Redd, A. Lynch, T. Vogt, S. Lewis et al., Chronic liver disease among two American Indian patient populations in the southwestern United States, J Clin Gastroenterol. août, vol.42, issue.7, pp.949-54, 2000.

S. Baumeister, H. Völzke, P. Marschall, U. John, C. Schmidt et al., Impact of Fatty Liver Disease on Health Care Utilization and Costs in a General Population: A 5-Year Observation, Gastroenterology, vol.134, issue.1, pp.85-94, 2008.
DOI : 10.1053/j.gastro.2007.10.024

M. Charlton, Nonalcoholic fatty liver disease: A review of current understanding and future impact, Clinical Gastroenterology and Hepatology, vol.2, issue.12, pp.1048-58, 2004.
DOI : 10.1016/S1542-3565(04)00440-9

C. Day and O. James, Steatohepatitis: A tale of two ???hits????, Gastroenterology, vol.114, issue.4, pp.842-847, 1998.
DOI : 10.1016/S0016-5085(98)70599-2

C. Day, From Fat to Inflammation, Gastroenterology, vol.130, issue.1, pp.207-217, 2006.
DOI : 10.1053/j.gastro.2005.11.017

A. Feldstein, N. Werneburg, A. Canbay, M. Guicciardi, S. Bronk et al., O0040 FREE FATTY ACIDS PROMOTE HEPATIC LIPOTOXICITY BY STIMULATING TNF-ALPHA EXPRESSION VIA A LYSOSOMAL PATHWAY, Journal of Pediatric Gastroenterology and Nutrition, vol.39, issue.Supplement 1, pp.185-94, 2004.
DOI : 10.1097/00005176-200406001-00042

K. Yamaguchi, L. Yang, S. Mccall, J. Huang, X. Yu et al., Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatology, vol.272, issue.6, pp.1366-74, 2007.
DOI : 10.1074/jbc.272.10.6093

S. Solga and A. Diehl, Non-alcoholic fatty liver disease: lumen???liver interactions and possible role for probiotics, Journal of Hepatology, vol.38, issue.5, pp.681-688, 2003.
DOI : 10.1016/S0168-8278(03)00097-7

J. Jou, S. Choi, and A. Diehl, Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease, Seminars in Liver Disease, vol.28, issue.04, pp.370-379, 2008.
DOI : 10.1055/s-0028-1091981

T. Roskams, S. Yang, A. Koteish, A. Durnez, R. Devos et al., Oxidative Stress and Oval Cell Accumulation in Mice and Humans with Alcoholic and Nonalcoholic Fatty Liver Disease, The American Journal of Pathology, vol.163, issue.4, pp.1301-1312, 2003.
DOI : 10.1016/S0002-9440(10)63489-X

J. Dowman, J. Tomlinson, and P. Newsome, Pathogenesis of non-alcoholic fatty liver disease, QJM, vol.103, issue.2, pp.71-83, 2010.
DOI : 10.1093/qjmed/hcp158

A. Poonawala, S. Nair, and P. Thuluvath, Prevalence of Obesity and Diabetes in Patients With Cryptogenic Cirrhosis: A Case-Control Study, Hepatology, vol.164, issue.4, pp.689-92, 2000.
DOI : 10.1053/jhep.2000.17894

S. Singh, A. Allen, Z. Wang, L. Prokop, M. Murad et al., Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies, Clinical Gastroenterology and Hepatology, vol.13, issue.4, pp.643-654, 2015.
DOI : 10.1016/j.cgh.2014.04.014

C. Argo, P. Northup, A. Osaimi, and S. Caldwell, Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis, Journal of Hepatology, vol.51, issue.2, pp.371-380, 2009.
DOI : 10.1016/j.jhep.2009.03.019

P. Angulo, D. Kleiner, S. Dam-larsen, L. Adams, E. Bjornsson et al., Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.149, issue.2, pp.389-397, 2015.
DOI : 10.1053/j.gastro.2015.04.043

P. Angulo, J. Keach, K. Batts, and K. Lindor, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, vol.93, issue.6, pp.1356-62, 1999.
DOI : 10.1002/hep.510300604

N. Hossain, A. Afendy, M. Stepanova, F. Nader, M. Srishord et al., Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology and Hepatology, vol.7, issue.11, pp.1224-1233, 2009.
DOI : 10.1016/j.cgh.2009.06.007

C. Matteoni, Z. Younossi, T. Gramlich, N. Boparai, Y. Liu et al., Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity???, ??????, Gastroenterology, vol.116, issue.6, pp.1413-1422, 1999.
DOI : 10.1016/S0016-5085(99)70506-8

V. Ratziu, P. Giral, C. F. Bruckert, E. Thibault, V. Theodorou et al., Liver fibrosis in overweight patients, Gastroenterology, vol.118, issue.6, pp.1117-1140, 2000.
DOI : 10.1016/S0016-5085(00)70364-7

S. Petta, M. Amato, D. Marco, V. Cammà, C. Pizzolanti et al., Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, vol.103, issue.2, pp.238-285, 2012.
DOI : 10.1111/j.1572-0241.2007.01774.x

J. Molloy, C. Calcagno, C. Williams, F. Jones, D. Torres et al., Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis, Hepatology, vol.139, issue.2, pp.429-465, 2012.
DOI : 10.1053/j.gastro.2010.06.048

D. White, F. Kanwal, and H. El-serag, Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review, Clinical Gastroenterology and Hepatology, vol.10, issue.12, pp.1342-1359, 2012.
DOI : 10.1016/j.cgh.2012.10.001

E. Hashimoto, S. Yatsuji, M. Tobari, M. Taniai, N. Torii et al., Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, Journal of Gastroenterology, vol.166, issue.suppl1, pp.89-95, 2009.
DOI : 10.1053/jhep.2003.50320

Y. Takuma and K. Nouso, Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: Our case series and literature review, World Journal of Gastroenterology, vol.16, issue.12, pp.1436-1477, 2010.
DOI : 10.3748/wjg.v16.i12.1436

M. Ekstedt, L. Franzén, U. Mathiesen, L. Thorelius, M. Holmqvist et al., Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology, vol.128, issue.4, pp.865-73, 2006.
DOI : 10.1002/hep.21327

N. Rafiq, C. Bai, Y. Fang, M. Srishord, A. Mccullough et al., Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver, Clinical Gastroenterology and Hepatology, vol.7, issue.2, pp.234-242, 2009.
DOI : 10.1016/j.cgh.2008.11.005

J. Ong, A. Pitts, and Z. Younossi, Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease, Journal of Hepatology, vol.49, issue.4, pp.608-620, 2008.
DOI : 10.1016/j.jhep.2008.06.018

C. Söderberg, P. Stål, J. Askling, H. Glaumann, G. Lindberg et al., Decreased survival of subjects with elevated liver function tests during a 28-year follow-up, Hepatology, vol.94, issue.2, pp.595-602, 2010.
DOI : 10.1002/ijc.1440

M. Lazo, R. Hernaez, S. Bonekamp, I. Kamel, F. Brancati et al., Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study, BMJ, vol.343, issue.nov18 2, p.6891, 2011.
DOI : 10.1136/bmj.d6891

D. Kim, W. Kim, H. Kim, and T. Therneau, Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States, Hepatology, vol.22, issue.4, pp.1357-65, 2013.
DOI : 10.1002/hep.1840220616

L. Adams, J. Lymp, S. Sauver, J. Sanderson, S. Lindor et al., The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study, Gastroenterology, vol.129, issue.1, pp.113-134, 2005.
DOI : 10.1053/j.gastro.2005.04.014

G. Musso, R. Gambino, M. Cassader, and G. Pagano, Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity, Annals of Medicine, vol.47, issue.1, pp.617-666, 2011.
DOI : 10.1590/S0004-28032010000200010

A. Sanyal, C. Banas, C. Sargeant, V. Luketic, R. Sterling et al., Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C, Hepatology, vol.36, issue.4, pp.682-691, 2006.
DOI : 10.3748/wjg.v11.i12.1848

H. Osawa and Y. Mori, Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes, Journal of Clinical Ultrasound, vol.137, issue.1, pp.25-34, 1996.
DOI : 10.1148/radiology.137.3.6934563

N. Schwenzer, F. Springer, C. Schraml, N. Stefan, J. Machann et al., Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance, Journal of Hepatology, vol.51, issue.3, pp.433-478, 2009.
DOI : 10.1016/j.jhep.2009.05.023

S. Strauss, E. Gavish, P. Gottlieb, and L. Katsnelson, Interobserver and Intraobserver Variability in the Sonographic Assessment of Fatty Liver, American Journal of Roentgenology, vol.189, issue.6, pp.320-323, 2007.
DOI : 10.2214/AJR.07.2123

S. Park, P. Kim, K. Kim, S. Lee, S. Yoon et al., Macrovesicular Hepatic Steatosis in Living Liver Donors: Use of CT for Quantitative and Qualitative Assessment, Radiology, vol.239, issue.1, pp.105-117, 2006.
DOI : 10.1148/radiol.2391050361

L. Szczepaniak, P. Nurenberg, D. Leonard, J. Browning, J. Reingold et al., Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, AJP: Endocrinology and Metabolism, vol.288, issue.2, pp.462-468, 2005.
DOI : 10.1152/ajpendo.00064.2004

J. Van-werven, H. Marsman, A. Nederveen, N. Smits, F. Ten-kate et al., H MR Spectroscopy, Radiology, vol.256, issue.1, pp.159-68, 2010.
DOI : 10.1148/radiol.10091790

M. Sasso, M. Beaugrand, V. De-ledinghen, C. Douvin, P. Marcellin et al., Controlled Attenuation Parameter (CAP): A Novel VCTE??? Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes, Ultrasound in Medicine & Biology, vol.36, issue.11, pp.1825-1860, 2010.
DOI : 10.1016/j.ultrasmedbio.2010.07.005

V. De-lédinghen, J. Vergniol, M. Capdepont, F. Chermak, J. Hiriart et al., Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations, Journal of Hepatology, vol.60, issue.5, pp.1026-1057, 2014.
DOI : 10.1016/j.jhep.2013.12.018

V. De-lédinghen, J. Vergniol, J. Foucher, W. Merrouche, and B. Le-bail, Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography, Liver International, vol.15, issue.6, pp.911-919, 2012.
DOI : 10.1016/j.anndiagpath.2010.08.001

F. Shen, R. Zheng, Y. Mi, X. Wang, Q. Pan et al., Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients, World Journal of Gastroenterology, vol.20, issue.16, pp.4702-4713, 2014.
DOI : 10.3748/wjg.v20.i16.4702

M. Kumar, A. Rastogi, T. Singh, C. Behari, E. Gupta et al., Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: Does etiology affect performance?, Journal of Gastroenterology and Hepatology, vol.51, issue.7, pp.1194-201, 2013.
DOI : 10.1016/j.jhep.2009.04.012

R. Myers, A. Pollett, R. Kirsch, G. Pomier-layrargues, M. Beaton et al., Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography, Liver International, vol.38, issue.Suppl. 1, pp.902-912, 2012.
DOI : 10.1016/j.dld.2006.03.021

W. Chan, N. Mustapha, N. Mahadeva, and S. , Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease, Journal of Gastroenterology and Hepatology, vol.25, issue.7, pp.1470-1476, 2014.
DOI : 10.1097/MEG.0b013e32835f4c3d

K. Imajo, T. Kessoku, Y. Honda, W. Tomeno, Y. Ogawa et al., Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography, Gastroenterology, vol.150, issue.3, pp.626-637, 2016.
DOI : 10.1053/j.gastro.2015.11.048

M. Lup?or-platon, D. Feier, H. Stef?nescu, A. Tamas, E. Botan et al., Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study, J Gastrointestin Liver Dis. mars, vol.24, issue.1, pp.35-42, 2015.

K. Korenblat, E. Fabbrini, B. Mohammed, and S. Klein, Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects, Gastroenterology, vol.134, issue.5, pp.1369-75, 2008.
DOI : 10.1053/j.gastro.2008.01.075

G. Targher, L. Bertolini, R. Padovani, S. Rodella, G. Zoppini et al., Relations Between Carotid Artery Wall Thickness and Liver Histology in Subjects With Nonalcoholic Fatty Liver Disease, Diabetes Care, vol.29, issue.6, pp.1325-1355, 2006.
DOI : 10.2337/dc06-0135

F. Fallo, D. Pozza, A. Sonino, N. Lupia, M. Tona et al., Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension, Nutrition, Metabolism and Cardiovascular Diseases, vol.19, issue.9, pp.646-53, 2009.
DOI : 10.1016/j.numecd.2008.12.007

C. Semenkovich, Insulin resistance and atherosclerosis, Journal of Clinical Investigation, vol.116, issue.7, pp.1813-1835, 2006.
DOI : 10.1172/JCI29024DS1

A. Kotronen, H. Yki-järvinen, K. Sevastianova, R. Bergholm, A. Hakkarainen et al., Comparison of the Relative Contributions of Intra-Abdominal and Liver Fat to Components of the Metabolic Syndrome, Obesity, vol.45, issue.1, pp.23-31, 2011.
DOI : 10.1152/ajpgi.00418.2003

J. Després, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu et al., Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.6, pp.1039-1088, 2008.
DOI : 10.1161/ATVBAHA.107.159228

A. Garg, Acquired and Inherited Lipodystrophies, New England Journal of Medicine, vol.350, issue.12, pp.1220-1254, 2004.
DOI : 10.1056/NEJMra025261

C. Lavie, R. Milani, A. Verma, O. Keefe, and J. , C-Reactive Protein and Cardiovascular Diseases???Is it Ready for Primetime?, The American Journal of the Medical Sciences, vol.338, issue.6, pp.486-92, 2009.
DOI : 10.1097/MAJ.0b013e3181c61b66

G. Targher, L. Bertolini, S. Rodella, G. Lippi, M. Franchini et al., NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men, Obesity, vol.112, issue.6, pp.1394-1403, 2008.
DOI : 10.1172/JCI200317797

J. Gaziano, C. Hennekens, O. Donnell, C. Breslow, J. Buring et al., Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction, Circulation, vol.96, issue.8, pp.2520-2525, 1997.
DOI : 10.1161/01.CIR.96.8.2520

E. Ruttmann, L. Brant, H. Concin, G. Diem, K. Rapp et al., ??-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults, Circulation, vol.112, issue.14, pp.2130-2137, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.552547

G. Wannamethee, S. Ebrahim, and A. Shaper, Gamma-glutamyltransferase: Determinants and Association with Mortality from Ischemic Heart Disease and All Causes, American Journal of Epidemiology, vol.142, issue.7, pp.699-708, 1995.
DOI : 10.1093/oxfordjournals.aje.a117699

D. Lee, K. Silventoinen, G. Hu, D. Jacobs, P. Jousilahti et al., Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women, European Heart Journal, vol.27, issue.18, pp.2170-2176, 2006.
DOI : 10.1093/eurheartj/ehl086

A. Kotronen and H. Yki-järvinen, Fatty Liver: A Novel Component of the Metabolic Syndrome, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.1, pp.27-38, 2008.
DOI : 10.1161/ATVBAHA.107.147538

R. Schindhelm, J. Dekker, G. Nijpels, L. Bouter, C. Stehouwer et al., Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study, Atherosclerosis, vol.191, issue.2, pp.391-397, 2007.
DOI : 10.1016/j.atherosclerosis.2006.04.006

W. Dunn, R. Xu, D. Wingard, C. Rogers, P. Angulo et al., Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study

K. Yun, C. Shin, Y. Yoon, and H. Park, Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans, Atherosclerosis, vol.205, issue.2, pp.533-540, 2009.
DOI : 10.1016/j.atherosclerosis.2008.12.012

A. Fraser, R. Harris, N. Sattar, S. Ebrahim, D. Smith et al., Alanine Aminotransferase, ??-Glutamyltransferase, and Incident Diabetes: The British Women's Heart and Health Study and meta-analysis, Diabetes Care, vol.32, issue.4, pp.741-50, 2009.
DOI : 10.2337/dc08-1870

G. Targher, L. Bertolini, S. Rodella, R. Tessari, L. Zenari et al., Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients, Diabetes Care, vol.30, issue.8, pp.2119-2140, 2007.
DOI : 10.2337/dc07-0349

M. Hamaguchi, T. Kojima, N. Takeda, C. Nagata, J. Takeda et al., Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease, World Journal of Gastroenterology, vol.13, issue.10, pp.1579-84, 2007.
DOI : 10.3748/wjg.v13.i10.1579

R. Haring, H. Wallaschofski, M. Nauck, M. Dörr, S. Baumeister et al., Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels, Hepatology, vol.54, issue.Pt 5, pp.1403-1414, 2009.
DOI : 10.1373/clinchem.2007.091959

M. Fishbein, F. Castro, S. Cheruku, S. Jain, B. Webb et al., Hepatic MRI for Fat Quantitation, Journal of Clinical Gastroenterology, vol.39, issue.7, pp.619-644, 2005.
DOI : 10.1097/00004836-200508000-00012

V. Ratziu, C. F. Heurtier, A. Gombert, S. Giral, P. Bruckert et al., Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.128, issue.7, pp.1898-906, 2005.
DOI : 10.1053/j.gastro.2005.03.084

A. Fraser, R. Harris, N. Sattar, S. Ebrahim, G. Smith et al., Gammaglutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis

Y. Zhou, Y. Li, Y. Nie, C. Huang, and C. Cao, Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study, Journal of Digestive Diseases, vol.12, issue.3, pp.153-60, 2012.
DOI : 10.1111/j.1751-2980.2010.00467.x

E. Azeem, H. Khalek, E. El-akabawy, H. Naeim, H. Khalik et al., Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events, Journal of the Saudi Heart Association, vol.25, issue.4, pp.239-285, 2013.
DOI : 10.1016/j.jsha.2013.07.004

P. Pisto, M. Santaniemi, R. Bloigu, O. Ukkola, and Y. Kesäniemi, Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study, BMJ Open, vol.4, issue.3, p.4973, 2014.
DOI : 10.1136/bmjopen-2014-004973

V. Wong, G. Wong, J. Yeung, C. Fung, J. Chan et al., Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study, Hepatology, vol.52, issue.3, pp.754-63, 2016.
DOI : 10.1016/j.jhep.2009.11.018

S. Moon, T. Noh, Y. Cho, S. Hong, S. Hyun et al., F-Fluorodeoxyglucose Positron Emission Tomography, Angiology, vol.234, issue.2, pp.472-80, 2015.
DOI : 10.1016/j.atherosclerosis.2014.03.001

P. Pickhardt, L. Hahn, M. Del-rio, A. Park, S. Reeder et al., Natural History of Hepatic Steatosis: Observed Outcomes for Subsequent Liver and Cardiovascular Complications, American Journal of Roentgenology, vol.202, issue.4, pp.752-760, 2014.
DOI : 10.2214/AJR.13.11367

M. Ekstedt, H. Hagström, P. Nasr, M. Fredrikson, P. Stål et al., Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up, Hepatology, vol.57, issue.5, pp.1547-54, 2015.
DOI : 10.1002/hep.26156

A. Fracanzani, S. Tiraboschi, G. Pisano, D. Consonni, A. Baragetti et al., Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10??years of follow-up, Atherosclerosis, vol.246, pp.208-221, 2016.
DOI : 10.1016/j.atherosclerosis.2016.01.016

P. Pignoli, E. Tremoli, A. Poli, P. Oreste, and R. Paoletti, Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging, Circulation, vol.74, issue.6, pp.1399-406, 1986.
DOI : 10.1161/01.CIR.74.6.1399

J. Kim, H. Youn, G. Kim, K. Moon, K. Yoo et al., The Clinical Significance of Separate Measurements of Carotid Arterial Wall to Assess the Risk Factor for Atherosclerosis, Journal of Cardiovascular Ultrasound, vol.24, issue.1, pp.48-54, 2016.
DOI : 10.4250/jcu.2016.24.1.48

G. Geroulakos, O. Gorman, D. Kalodiki, E. Sheridan, D. Nicolaides et al., The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease, European Heart Journal, vol.15, issue.6, pp.781-786, 1994.
DOI : 10.1093/oxfordjournals.eurheartj.a060585

O. Leary, D. Polak, J. Kronmal, R. Manolio, T. Burke et al., Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults, New England Journal of Medicine, vol.340, issue.1, pp.14-22, 1999.
DOI : 10.1056/NEJM199901073400103

P. Allan, P. Mowbray, A. Lee, and F. Fowkes, Relationship Between Carotid Intima-Media Thickness and Symptomatic and Asymptomatic Peripheral Arterial Disease: The Edinburgh Artery Study, Stroke, vol.28, issue.2, pp.348-53, 1997.
DOI : 10.1161/01.STR.28.2.348

T. Naqvi and M. Lee, Carotid Intima-Media Thickness and Plaque??in Cardiovascular Risk Assessment, JACC: Cardiovascular Imaging, vol.7, issue.10, pp.1025-1063, 2014.
DOI : 10.1016/j.jcmg.2013.11.014

P. Touboul, M. Hennerici, S. Meairs, H. Adams, P. Amarenco et al., Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004??2006??2011), An Update on Behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium 13th and 15th European Stroke Conferences, pp.290-296, 2004.
DOI : 10.1159/000343145

C. Aygun, O. Kocaman, T. Sahin, S. Uraz, A. Eminler et al., Evaluation of Metabolic Syndrome Frequency and Carotid Artery Intima-media Thickness as Risk Factors for Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease, Digestive Diseases and Sciences, vol.42, issue.suppl, pp.1352-1359, 2008.
DOI : 10.3748/wjg.v11.i12.1848

A. Brea, D. Mosquera, E. Martín, A. Arizti, J. Cordero et al., Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case-Control Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.5, pp.1045-50, 2005.
DOI : 10.1161/01.ATV.0000160613.57985.18

S. Ramilli, S. Pretolani, A. Muscari, B. Pacelli, and V. Arienti, Carotid lesions in outpatients with nonalcoholic fatty liver disease, World Journal of Gastroenterology, vol.15, issue.38, pp.4770-4774, 2009.
DOI : 10.3748/wjg.15.4770

A. Mohammadi, H. Sedani, and M. Ghasemi-rad, Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease, Vasc Health Risk Manag, vol.7, pp.661-666, 2011.

Y. Huang, Y. Bi, M. Xu, Z. Ma, Y. Xu et al., Nonalcoholic Fatty Liver Disease Is Associated With Atherosclerosis in Middle-Aged and Elderly Chinese, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.9, pp.2321-2327, 2012.
DOI : 10.1161/ATVBAHA.112.252957

J. Kang, K. Cho, S. Kim, J. Lee, J. Kim et al., Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients, Journal of Cardiovascular Ultrasound, vol.20, issue.3, pp.126-159, 2012.
DOI : 10.4250/jcu.2012.20.3.126

M. Thakur, S. Sharma, A. Kumar, S. Bhatt, K. Luthra et al., Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians, Atherosclerosis, vol.223, issue.2, pp.507-518, 2012.
DOI : 10.1016/j.atherosclerosis.2012.06.005

H. Volzke, D. Robinson, V. Kleine, R. Deutscher, W. Hoffmann et al., Hepatic steatosis is associated with an increased risk of carotid atherosclerosis, World Journal of Gastroenterology, vol.11, issue.12, pp.1848-53, 2005.
DOI : 10.3748/wjg.v11.i12.1848

P. Salvi, R. Ruffini, D. Agnoletti, E. Magnani, G. Pagliarani et al., Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study, Journal of Hypertension, vol.28, issue.8, pp.1699-707, 2010.
DOI : 10.1097/HJH.0b013e32833a7de6

H. Kim, D. Kim, and K. Huh, Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome, Atherosclerosis, vol.204, issue.2, pp.521-526, 2009.
DOI : 10.1016/j.atherosclerosis.2008.09.012

S. Kim, Y. Choi, B. Huh, S. Park, E. Lee et al., Nonalcoholic Fatty Liver Disease Is Associated With Increased Carotid Intima-Media Thickness Only in Type 2 Diabetic Subjects With Insulin Resistance, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.5, pp.1879-84, 2014.
DOI : 10.1210/jc.2013-4133

C. Wang, S. Lin, Y. Tseng, C. Hsu, T. Tseng et al., Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease, Journal of Gastroenterology and Hepatology, vol.355, issue.8, pp.1411-1417, 2009.
DOI : 10.1007/BF03347199

A. Lonardo, S. Lombardini, F. Scaglioni, S. Ballestri, A. Verrone et al., Fatty liver, carotid disease and gallstones: A study of age-related associations, World Journal of Gastroenterology, vol.12, issue.36, pp.5826-5859, 2006.
DOI : 10.3748/wjg.v12.i36.5826

J. Petit, B. Guiu, B. Terriat, R. Loffroy, R. I. Petit et al., Nonalcoholic Fatty Liver Is Not Associated with Carotid Intima-Media Thickness in Type 2 Diabetic Patients, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.10, pp.4103-4109, 2009.
DOI : 10.1210/jc.2009-0541

G. Targher, L. Bertolini, R. Padovani, F. Poli, L. Scala et al., Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients, Journal of Endocrinological Investigation, vol.123, issue.1, pp.55-60, 2006.
DOI : 10.1053/gast.2002.35354

A. Fracanzani, L. Burdick, S. Raselli, P. Pedotti, L. Grigore et al., Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease, The American Journal of Medicine, vol.121, issue.1, pp.72-80, 2008.
DOI : 10.1016/j.amjmed.2007.08.041

S. Neri, S. Signorelli, R. Scuderi, M. Bruno, G. Bertino et al., Carotid Intima-Media Thickness and Liver Histology in Hemodialysis Patients with Nonalcoholic Fatty Liver Disease, International Journal of Angiology, vol.20, issue.03, pp.149-56, 2011.
DOI : 10.1055/s-0031-1283218

L. Valenti, D. Swinkels, L. Burdick, P. Dongiovanni, H. Tjalsma et al., Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease, Nutrition, Metabolism and Cardiovascular Diseases, vol.21, issue.8, pp.568-75, 2011.
DOI : 10.1016/j.numecd.2010.01.003

K. Kim, H. Oh, D. Kim, S. Kim, S. Park et al., The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels, Endocrine Journal, vol.60, issue.12, pp.1295-301, 2013.
DOI : 10.1507/endocrj.EJ13-0269

S. Petta, L. Valenti, G. Marchesini, D. Marco, V. Licata et al., PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease, PLoS ONE, vol.55, issue.9, p.74089, 2013.
DOI : 10.1371/journal.pone.0074089.s002

A. Lee, J. Price, M. Russell, F. Smith, M. Van-wijk et al., Improved Prediction of Fatal Myocardial Infarction Using the Ankle Brachial Index in Addition to Conventional Risk Factors: The Edinburgh Artery Study, Circulation, vol.110, issue.19, pp.3075-80, 2004.
DOI : 10.1161/01.CIR.0000143102.38256.DE

P. Grousseau, Dépistage de la fibrose hépatique par FibroScan® chez les patients ayant fait un accident cardio-vasculaire ischémique [Thèse d'exercice]

S. Forsdahl, K. Singh, S. Solberg, and B. Jacobsen, Risk Factors for Abdominal Aortic Aneurysms: A 7-Year Prospective Study: The Tromso Study, 1994-2001, Circulation, vol.119, issue.16, pp.2202-2210, 1994.
DOI : 10.1161/CIRCULATIONAHA.108.817619

C. Iribarren, J. Darbinian, A. Go, B. Fireman, C. Lee et al., Traditional and Novel Risk Factors for Clinically Diagnosed Abdominal Aortic Aneurysm: The Kaiser Multiphasic Health Checkup Cohort Study, Annals of Epidemiology, vol.17, issue.9, pp.669-78, 2007.
DOI : 10.1016/j.annepidem.2007.02.004

J. Stein, M. Fraizer, S. Aeschlimann, J. Nelson-worel, P. Mcbride et al., Vascular age: Integrating carotid intima-media thickness measurements with global coronary risk assessment, Clinical Cardiology, vol.15, issue.7, pp.388-92, 2004.
DOI : 10.1111/jon19911268

S. Grundy, J. Cleeman, S. Daniels, K. Donato, R. Eckel et al., Diagnosis and management of the metabolic syndrome, Current Opinion in Cardiology, vol.21, issue.1, pp.2735-52, 2005.
DOI : 10.1097/01.hco.0000200416.65370.a0

G. Targher and C. Byrne, Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease, Nature Reviews Nephrology, vol.6, issue.5, pp.297-310, 2017.
DOI : 10.1152/ajpgi.00346.2014

B. Coll and S. Feinstein, Carotid intima-media thickness measurements: Techniques and clinical relevance, Current Atherosclerosis Reports, vol.48, issue.5, pp.444-50, 2008.
DOI : 10.1161/01.STR.27.2.224

Y. Plantinga, S. Dogan, D. Grobbee, and M. Bots, Carotid intima-media thickness measurement in cardiovascular screening programmes, European Journal of Cardiovascular Prevention & Rehabilitation, vol.338, issue.1, pp.639-683, 2009.
DOI : 10.1136/bmj.b375

D. Ruijter, H. Peters, S. Anderson, T. Britton, A. Dekker et al., Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction, JAMA, vol.308, issue.8, pp.796-803, 2012.
DOI : 10.1001/jama.2012.9630

S. Van-den-oord, E. Sijbrands, G. Ten-kate, D. Van-klaveren, R. Van-domburg et al., Carotid intima-media thickness for cardiovascular risk assessment: Systematic review and meta-analysis, Atherosclerosis, vol.228, issue.1, pp.1-11, 2013.
DOI : 10.1016/j.atherosclerosis.2013.01.025

Y. Zhang, E. Guallar, Y. Qiao, and B. Wasserman, Is Carotid Intima-Media Thickness as Predictive as Other Noninvasive Techniques for the Detection of Coronary Artery Disease?, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.34, issue.7, pp.1341-1346, 2014.
DOI : 10.1161/ATVBAHA.113.302075

D. Goff, L. , D. Bennett, G. Coady, S. et al., AHA Guideline on the Assessment of Cardiovascular Risk, ACC Circulation. 1 janv, 2013.

M. Owolabi, O. Akpa, and A. Agunloye, Carotid IMT is more associated with stroke than risk calculators, Acta Neurologica Scandinavica, vol.107, issue.6, pp.442-50, 2016.
DOI : 10.1016/j.amjcard.2010.08.054

P. Touboul, J. Labreuche, E. Vicaut, and P. Amarenco, Carotid Intima-Media Thickness, Plaques, and Framingham Risk Score as Independent Determinants of Stroke Risk, Stroke, vol.36, issue.8, pp.1741-1746, 2005.
DOI : 10.1161/01.STR.0000174490.23495.57

C. Bonithon-kopp, P. Touboul, C. Berr, C. Leroux, F. Mainard et al., Relation of Intima-Media Thickness to Atherosclerotic Plaques in Carotid Arteries : The Vascular Aging (EVA) Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.16, issue.2, pp.310-316, 1996.
DOI : 10.1161/01.ATV.16.2.310

A. Finn, F. Kolodgie, and R. Virmani, Correlation Between Carotid Intimal/Medial Thickness and Atherosclerosis: A Point of View From Pathology, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.2, pp.177-81, 2010.
DOI : 10.1161/ATVBAHA.108.173609

Y. Inaba, J. Chen, and S. Bergmann, Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: A meta-analysis, Atherosclerosis, vol.220, issue.1, pp.128-161, 2012.
DOI : 10.1016/j.atherosclerosis.2011.06.044

J. Spence, Carotid plaque measurement is superior to IMT Invited editorial comment on: carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis

S. Johnsen, E. Mathiesen, O. Joakimsen, E. Stensland, T. Wilsgaard et al., Carotid Atherosclerosis Is a Stronger Predictor of Myocardial Infarction in Women Than in Men: A 6-Year Follow-Up Study of 6226 Persons: The Tromso Study, Stroke, vol.38, issue.11, pp.2873-80, 2007.
DOI : 10.1161/STROKEAHA.107.487264

V. Wong, J. Vergniol, G. Wong, J. Foucher, H. Chan et al., Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease, Hepatology, vol.50, issue.Suppl 1, pp.454-62, 2010.
DOI : 10.1016/S0168-8278(09)60991-0

C. Park, P. Nguyen, C. Hernandez, R. Bettencourt, K. Ramirez et al., Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.152, issue.3, pp.598-607, 2017.
DOI : 10.1053/j.gastro.2016.10.026